Where the money is: Top 100 VCs investing in US biotechs during 2017
It was a big year for US biotechs raising cash from VCs, with flush investors sinking a record-breaking $10.5 billion into new and growing companies during 2017. Who’s deploying the dollars, and where’s the money coming from? We put together a fresh list of the top 100 VC firms investing in US biotechs, and the data might surprise you.
While there’s a lot of repeat players, we’re also seeing an interesting shift in where big money is coming from. Back in 2015, four of the top five VCs were based in Boston/Cambridge. This year, three out of the top five VCs were based in the San Francisco Bay Area. Only one was from Massachusetts.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.